<!DOCTYPE html>
<html lang="en-us">
<head>

  <meta charset="utf-8">
  <meta name="viewport" content="width=device-width, initial-scale=1">
  <meta http-equiv="X-UA-Compatible" content="IE=edge">
  <meta name="theme" content="hugo-academic">
  <meta name="generator" content="Hugo 0.18.1" />
  <meta name="author" content="Sean Davis">
  

  
  
  
    
  
  
    
    
    <link rel="stylesheet" href="/css/highlight.min.css">
    
  
  <link rel="stylesheet" href="/css/bootstrap.min.css">
  <link rel="stylesheet" href="/css/font-awesome.min.css">
  <link rel="stylesheet" href="/css/academicons.min.css">
  <link rel="stylesheet" href="//fonts.googleapis.com/css?family=Lato:400,700|Merriweather|Roboto+Mono">
  <link rel="stylesheet" href="/css/hugo-academic.css">
  

  <link rel="alternate" href="https://seandavi.github.io/index.xml" type="application/rss+xml" title="Sean Davis">
  <link rel="feed" href="https://seandavi.github.io/index.xml" type="application/rss+xml" title="Sean Davis">

  <link rel="icon" type="image/png" href="/img/icon.png">
  <link rel="apple-touch-icon" type="image/png" href="/img/apple-touch-icon.png">

  <link rel="canonical" href="https://seandavi.github.io/publication/25940539/">

  

  <title>Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer. | Sean Davis</title>

</head>
<body id="top" data-spy="scroll" data-target="#navbar-main" data-offset="71">

<nav class="navbar navbar-default navbar-fixed-top" id="navbar-main">
  <div class="container">

    
    <div class="navbar-header">
      <button type="button" class="navbar-toggle collapsed" data-toggle="collapse"
              data-target=".navbar-collapse" aria-expanded="false">
        <span class="sr-only">Toggle navigation</span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
        <span class="icon-bar"></span>
      </button>
      <a class="navbar-brand" href="/">Sean Davis</a>
    </div>

    
    <div class="collapse navbar-collapse">

      
      <ul class="nav navbar-nav navbar-right">
        

        

        <li class="nav-item">
          <a href="/#about">
            
            <span>Home</span>
          </a>
        </li>

        
        

        

        <li class="nav-item">
          <a href="/#publications_selected">
            
            <span>Publications</span>
          </a>
        </li>

        
        

        

        <li class="nav-item">
          <a href="/#posts">
            
            <span>Posts</span>
          </a>
        </li>

        
        

        

        <li class="nav-item">
          <a href="/#projects">
            
            <span>Projects</span>
          </a>
        </li>

        
        

        

        <li class="nav-item">
          <a href="/#teaching">
            
            <span>Teaching</span>
          </a>
        </li>

        
        

        

        <li class="nav-item">
          <a href="/#contact">
            
            <span>Contact</span>
          </a>
        </li>

        
        
      </ul>

    </div>
  </div>
</nav>

<div class="pub" itemscope itemtype="http://schema.org/CreativeWork">

  

  <div class="container pub-title">
    <h1 itemprop="name">Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer.</h1>
    <span class="pub-authors" itemprop="author">
      
      Lisa Zhang, Yaqin Zhang, Amit Mehta, Myriem Boufraqech, Sean Davis, Jing Wang, Ze Tian, Zhiya Yu, Matthew B Boxer, Jeffrey A Kiefer, John A Copland, Robert C Smallridge, Zhuyin Li, Min Shen, Electron Kebebew
      
    </span>
    <span class="pull-right">
      
<div class="share-box" aria-hidden="true">
  <ul class="share">
    <li>
      <a class="facebook"
         href="https://www.facebook.com/sharer.php?u=https%3a%2f%2fseandavi.github.io%2fpublication%2f25940539%2f"
         target="_blank">
        <i class="fa fa-facebook"></i>
      </a>
    </li>
    <li>
      <a class="twitter"
         href="https://twitter.com/intent/tweet?text=Dual%20inhibition%20of%20HDAC%20and%20EGFR%20signaling%20with%20CUDC-101%20induces%20potent%20suppression%20of%20tumor%20growth%20and%20metastasis%20in%20anaplastic%20thyroid%20cancer.&amp;url=https%3a%2f%2fseandavi.github.io%2fpublication%2f25940539%2f"
         target="_blank">
        <i class="fa fa-twitter"></i>
      </a>
    </li>
    <li>
      <a class="linkedin"
         href="https://www.linkedin.com/shareArticle?mini=true&amp;url=https%3a%2f%2fseandavi.github.io%2fpublication%2f25940539%2f&amp;title=Dual%20inhibition%20of%20HDAC%20and%20EGFR%20signaling%20with%20CUDC-101%20induces%20potent%20suppression%20of%20tumor%20growth%20and%20metastasis%20in%20anaplastic%20thyroid%20cancer."
         target="_blank">
        <i class="fa fa-linkedin"></i>
      </a>
    </li>
    <li>
      <a class="weibo"
         href="http://service.weibo.com/share/share.php?url=https%3a%2f%2fseandavi.github.io%2fpublication%2f25940539%2f&amp;title=Dual%20inhibition%20of%20HDAC%20and%20EGFR%20signaling%20with%20CUDC-101%20induces%20potent%20suppression%20of%20tumor%20growth%20and%20metastasis%20in%20anaplastic%20thyroid%20cancer."
         target="_blank">
        <i class="fa fa-weibo"></i>
      </a>
    </li>
    <li>
      <a class="email"
         href="mailto:?subject=Dual%20inhibition%20of%20HDAC%20and%20EGFR%20signaling%20with%20CUDC-101%20induces%20potent%20suppression%20of%20tumor%20growth%20and%20metastasis%20in%20anaplastic%20thyroid%20cancer.&amp;body=https%3a%2f%2fseandavi.github.io%2fpublication%2f25940539%2f">
        <i class="fa fa-envelope"></i>
      </a>
    </li>
  </ul>
</div>


    </span>
  </div>

</div>
<div class="article-container">

  

  <h3>Abstract</h3>
  <p class="pub-abstract" itemprop="text">Anaplastic thyroid cancer (ATC) is one of the most lethal human malignancies that currently has no effective therapy. We performed quantitative high-throughput screening (qHTS) in three ATC cell lines using 3,282 clinically approved drugs and drug candidates, and identified 100 active agents. Enrichment analysis of active compounds showed that inhibitors of EGFR and histone deacetylase (HDAC) were most active. Of these, the first-in-class dual inhibitor of EGFR, HER2 and HDACs, CUDC-101, had the highest efficacy and lower IC50 than established drugs. We validated that CUDC-101 inhibited cellular proliferation and resulted in cell death by inducing cell cycle arrest and caspase-dependent apoptosis. CUDC-101 also inhibited cellular migration in vitro. Mechanistically, CUDC-101 inhibited MAPK signaling and histone deacetylation in ATC cell lines with multiple driver mutations present in human ATC. The anticancer effect of CUDC-101 was associated with increased expression of p21 and E-cadherin, and reduced expression of survivin, XIAP, Î²-catenin, N-cadherin, and Vimentin. In an in vivo mouse model of metastatic ATC, CUDC-101 inhibited tumor growth and metastases, and significantly prolonged survival. Response to CUDC-101 treatment in vivo was associated with increased histone 3 acetylation and reduced survivin expression. Our findings provide a preclinical basis to evaluate CUDC-101 therapy in ATC.</p>

  
  <div class="row">
    <div class="col-sm-1"></div>
    <div class="col-sm-10">
      <div class="row">
        <div class="col-xs-12 col-sm-3 pub-row-heading">Type</div>
        <div class="col-xs-12 col-sm-9">
          
          <a href="/publication/#2">
            Journal
          </a>
          
        </div>
      </div>
    </div>
    <div class="col-sm-1"></div>
  </div>
  <div class="visible-xs space-below"></div>
  

  <div class="row">
    <div class="col-sm-1"></div>
    <div class="col-sm-10">
      <div class="row">
        <div class="col-xs-12 col-sm-3 pub-row-heading">Publication</div>
        <div class="col-xs-12 col-sm-9">In Oncotarget</div>
      </div>
    </div>
    <div class="col-sm-1"></div>
  </div>
  <div class="visible-xs space-below"></div>

  <div class="row">
    <div class="col-sm-1"></div>
    <div class="col-sm-10">
      <div class="row">
        <div class="col-xs-12 col-sm-3 pub-row-heading">Date</div>
        <div class="col-xs-12 col-sm-9" itemprop="datePublished">
          May, 2015
        </div>
      </div>
    </div>
    <div class="col-sm-1"></div>
  </div>
  <div class="visible-xs space-below"></div>

  <div class="row" style="padding-top: 10px">
    <div class="col-sm-1"></div>
    <div class="col-sm-10">
      <div class="row">
        <div class="col-xs-12 col-sm-3 pub-row-heading" style="line-height:34px;">Links</div>
        <div class="col-xs-12 col-sm-9">

          










<a class="btn btn-primary btn-outline" href="https://www.ncbi.nlm.nih.gov/pubmed/25940539">
  Pubmed
</a>



        </div>
      </div>
    </div>
    <div class="col-sm-1"></div>
  </div>
  <div class="visible-xs space-below"></div>

  <div class="space-below"></div>

  <div class="article-style"></div>

</div>

<div class="container">
  <nav>
  <ul class="pager">
    
    <li class="previous"><a href="https://seandavi.github.io/publication/25929339/"><span
      aria-hidden="true">&larr;</span> Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer.</a></li>
    

    
    <li class="next"><a href="https://seandavi.github.io/publication/25944801/">Inhibition of Survivin with YM155 Induces Durable Tumor Response in Anaplastic Thyroid Cancer. <span
      aria-hidden="true">&rarr;</span></a></li>
    
  </ul>
</nav>

</div>

<footer class="site-footer">
  <div class="container">
    <p class="powered-by">

      &copy; 2017 Sean Davis &middot; 

      Powered by the <a href="https://github.com/gcushen/hugo-academic" target="_blank">Academic
      theme</a> for <a href="http://gohugo.io" target="_blank">Hugo</a>.

      <span class="pull-right" aria-hidden="true">
        <a href="#" id="back_to_top">
          <span class="button_icon">
            <i class="fa fa-chevron-up fa-2x"></i>
          </span>
        </a>
      </span>

    </p>
  </div>
</footer>

    <script src="//cdnjs.cloudflare.com/ajax/libs/gsap/1.18.4/TweenMax.min.js"></script>
    <script src="//cdnjs.cloudflare.com/ajax/libs/gsap/latest/plugins/ScrollToPlugin.min.js"></script>
    <script src="/js/jquery-1.12.3.min.js"></script>
    <script src="/js/bootstrap.min.js"></script>
    <script src="/js/isotope.pkgd.min.js"></script>
    <script src="//cdnjs.cloudflare.com/ajax/libs/jquery.imagesloaded/4.1.1/imagesloaded.pkgd.min.js"></script>
    <script src="/js/hugo-academic.js"></script>
    

    
    <script>
        (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
        (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
        m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
        })(window,document,'script','https://www.google-analytics.com/analytics.js','ga');
        ga('create', 'UA-93043521-1', 'auto');
        ga('send', 'pageview');

         
        var links = document.querySelectorAll('a');
        Array.prototype.map.call(links, function(item) {
            if (item.host != document.location.host) {
                item.addEventListener('click', function() {
                    var action = item.getAttribute('data-action') || 'follow';
                    ga('send', 'event', 'outbound', action, item.href);
                });
            }
        });
    </script>
    

    
    
      
      <script src="//cdnjs.cloudflare.com/ajax/libs/highlight.js/9.9.0/highlight.min.js"></script>

      

      

      <script>hljs.initHighlightingOnLoad();</script>
    

    
    
    <script type="text/x-mathjax-config">
        MathJax.Hub.Config({ tex2jax: { inlineMath: [['$','$'], ['\\(','\\)']] } });
    </script>
    <script async src="//cdn.mathjax.org/mathjax/latest/MathJax.js?config=TeX-AMS_CHTML"></script>
    

  </body>
</html>

